GlassScriptPhysician profile
Dionne Oliver
NPI 1669486452
$4,866.06
in general payments reported to CMS, 2019-2025
38 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,922 · 2020: $495 · 2021: $455 · 2022: $145 · 2023: $1,401 · 2024: $253 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.81 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,498.77 | 2019-2020 | |
| Ibsa Pharma INC. | $1,025.00 | 2023 | Tirosint |
| Abbvie INC. | $489.65 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $254.17 | 2021-2025 | |
| Exeltis, USA INC. | $167.00 | 2019-2025 | Slynd |
| Novo Nordisk INC | $142.21 | 2020-2024 | |
| Aspira Women'S Health INC | $124.27 | 2020-2025 | Ova1 |
| Astellas Pharma US INC | $112.25 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $91.31 | 2023-2024 | Accrufer |
| Mylan Pharmaceuticals INC. | $80.65 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $78.73 | 2019-2020 | |
| Coopersurgical, INC. | $69.44 | 2019 | |
| Renovia INC | $60.34 | 2020 | |
| Lupin INC. | $55.96 | 2019-2020 | |
| Lilly USA, LLC | $53.84 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dionne Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.